Related Experiment Video

Updated: Jul 16, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

[Arteriosclerosis and vascular calcification in chronic kidney disease (CKD) patients]

Yuri Masho1, Takashi Shigematsu

  • 1Saiseikai Wakayama hospital, Division of Dialysis Center.

Clinical Calcium
|March 7, 2007
PubMed

Insights

Patients with chronic kidney disease (CKD) face high risks of vascular calcification and atherosclerosis. Managing CKD-related metabolic bone disorder is crucial for preventing cardiovascular events.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biochemistry

Context:

  • Chronic kidney disease (CKD) significantly elevates atherosclerosis and vascular calcification risk.
  • CKD patients, especially those on long-term dialysis, exhibit advanced arteriosclerosis and medial calcification.
  • Cardiovascular mortality is a major concern in CKD patients due to these vascular complications.

Purpose:

  • To elucidate the mechanisms of vascular calcification in CKD.
  • To identify key factors contributing to vascular calcification in CKD patients.
  • To highlight the role of CKD-related metabolic bone disorder (CKD-MBD) in disease progression.

Summary:

  • Vascular calcification in CKD is multifactorial, exacerbated by CKD-MBD involving calcium, phosphate, and parathyroid hormone (PTH) imbalances.
  • Hyperphosphatemia is a critical risk factor impacting patient survival.
  • Effective management requires maintaining serum phosphorus, calcium, and PTH within optimal ranges.

Impact:

  • Understanding these mechanisms is vital for preventing vascular calcification and reducing cardiovascular mortality in CKD.
  • New phosphate binders are under development to mitigate hyperphosphatemia and improve patient outcomes.
  • Focus on novel therapeutic agents aims to enhance survival rates for CKD patients.

More Related Videos

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...